Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
CRISPR Therapeutics
ISIN CH0334081137
|WKN A2AT0Z
Marktkapitalisatie (in EUR)
4,459 m
Land
Switzerland
Sector
Healthcare
Dividendrendement
0.00%
Overzicht
Beschrijving
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland
Financiële kerngegevens
Kerncijfers
| Marktkapitalisatie, EUR | 4,459 m |
| WPA, EUR | -5.77 |
| KBV | 2.7 |
| K/W | - |
| Dividendrendement | 0.00% |
Income statement (2025)
| Omzet, EUR | 3 m |
| Netto-inkomen, EUR | -516 m |
| Winstmarge | -16,569.77% |
What ETF is CRISPR Therapeutics in?
There are 4 ETFs which contain CRISPR Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of CRISPR Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
| ETF | Weging | Investeringsfocus | Fondsgrootte (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.38% | Equity United States Health Care Biotech | 47 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 490 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 24 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.08% | Equity United States Small Cap | 191 |
Nieuwste artikelen
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.